Literature DB >> 10195633

Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites.

E D Franke1, S L Hoffman, J B Sacci, R Wang, Y Charoenvit, E Appella, R Chesnut, J Alexander, M F Del Guercio, A Sette.   

Abstract

Pan-DR epitope (PADRE) peptides have demonstrated the capacity to deliver help for antibody responses in vivo. They were also found, fortuitously, to be able to provide significant helper T-cell activity in vivo. This suggested that linear constructs, containing the PADRE epitope, might be as efficient at generating an immune response as large multivalent antigens. Plasmodium falciparum and P. yoelii PADRE constructs were capable of inducing a high titre IgG antibody response that recognized intact sporozoites. We now report that these antibodies can inhibit sporozoite invasion of hepatocytes in vitro and that mice immunized with the PyCSP-PADRE linear construct were protected when challenged with P. yoelii sporozoites.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195633     DOI: 10.1016/s0264-410x(98)00341-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  A subdominant CD8(+) cytotoxic T lymphocyte (CTL) epitope from the Plasmodium yoelii circumsporozoite protein induces CTLs that eliminate infected hepatocytes from culture.

Authors:  E D Franke; A Sette; J Sacci; S Southwood; G Corradin; S L Hoffman
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 2.  Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?

Authors:  Bruno Douradinha; Maria M Mota; Adrian J F Luty; Robert W Sauerwein
Journal:  Infect Immun       Date:  2007-12-03       Impact factor: 3.441

Review 3.  Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccines.

Authors:  Godfree Mlambo; Nirbhay Kumar
Journal:  Eukaryot Cell       Date:  2008-09-19

Review 4.  Trial watch: DNA-based vaccines for oncological indications.

Authors:  Stefano Pierini; Renzo Perales-Linares; Mireia Uribe-Herranz; Jonathan G Pol; Laurence Zitvogel; Guido Kroemer; Andrea Facciabene; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2017-11-20       Impact factor: 8.110

5.  A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.

Authors:  J Mauricio Calvo-Calle; Giane A Oliveira; Carol Othoro Watta; Jonathan Soverow; Carlos Parra-Lopez; Elizabeth H Nardin
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

6.  Construction of exogenous multiple epitopes of helper T lymphocytes and DNA immunization of its chimeric plasmid with HBV pre-S2/S gene.

Authors:  Wen-Jun Gao; Xiao-Mou Peng; Dong-Ying Xie; Qi-Feng Xie; Zhi-Liang Gao; Ji-Lu Yao
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

7.  Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer.

Authors:  A Wu; Q Zeng; T H Kang; S Peng; E Roosinovich; S I Pai; C-F Hung
Journal:  Gene Ther       Date:  2010-10-28       Impact factor: 5.250

8.  Enhanced immunogenicity of a functional enzyme by T cell epitope modification.

Authors:  Jeanette M Mucha; Marcia M Stickler; A J Poulose; Grant Ganshaw; Mae Saldajeno; Kathy Collier; Manley T Huang; Fiona A Harding
Journal:  BMC Immunol       Date:  2002-01-25       Impact factor: 3.615

Review 9.  Trial Watch: Peptide-based anticancer vaccines.

Authors:  Jonathan Pol; Norma Bloy; Aitziber Buqué; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-01-09       Impact factor: 8.110

10.  Production and evaluation of virus-like particles displaying immunogenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV).

Authors:  Ambika Mosale Venkatesh Murthy; Yanyan Ni; Xiangjin Meng; Chenming Zhang
Journal:  Int J Mol Sci       Date:  2015-04-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.